Acetyl salicyclic acid (aspirin) improves synthesis of maspin and lowers incidence of metastasis in breast cancer patients
- 25 June 2010
- journal article
- Published by Wiley in Cancer Science
- Vol. 101 (10) , 2105-2109
Abstract
Maspin, a 42 kDa protein produced in normal breast cells, has been shown to inhibit the invasion and metastasis of breast cancer in an animal model. Ingestion of acetylsalicylic acid (aspirin) by breast cancer patients has been reported to restore the systemic synthesis of maspin through the stimulation of systemic nitric oxide production. Studies were carried out to determine the effect of aspirin on the incidence of breast cancer metastasis, which is reported to occur in 50% of patients who have previously received chemotherapy, radiation, and/or surgery. Thirty‐five female patients (aged 41–65 years) with breast cancer who had previously received these therapies took one 75 mg/70 kg body weight enteric‐coated aspirin tablet every 24 h, after an adequate meal, for 3 years. Their plasma nitric oxide and maspin levels were measured. The occurrence of metastasis was ascertained monthly by a qualified oncologist, and confirmed, if necessary, by biopsy. Daily ingestion of aspirin by participants resulted in an increase in maspin levels from 0.95 ± 0.04 to 4.63 ± 0.05 nM after 24 h. These levels were maintained for 3 years. These studies suggest that daily ingestion of aspirin might significantly reduce the incidence of breast cancer metastasis in patients who have previously received anticancer therapies. (Cancer Sci 2010)Keywords
This publication has 19 references indexed in Scilit:
- Restoration by aspirin of impaired plasma maspin level in human breast cancerActa Oncologica, 2006
- Aspirin Resistance and Atherothrombotic DiseaseJACC, 2005
- Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirinPlatelets, 2003
- Neutralization by "antineoplastin" of insulin-activated nitric oxide synthase antibody and its effects in cancersJournal of Cancer Research and Clinical Oncology, 2002
- Cancer immunotherapy: The interferon-α experienceSeminars in Oncology, 2002
- Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breastThe Journal of Pathology, 2001
- S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular controlNature, 1996
- Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial CellsScience, 1994
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Cell‐Free Synthesis of the Mitochondrial ADP/ATP Carrier Protein of Neurospora crassaEuropean Journal of Biochemistry, 1979